Pages that link to "Q23832736"
Jump to navigation
Jump to search
The following pages link to Botulinum Toxin as a Biological Weapon: Medical and Public Health Management (Q23832736):
Displaying 50 items.
- botulinum toxin type A (Q4095199) (← links)
- Botulism (Q21994439) (← links)
- Botulinum neurotoxin detection and differentiation by mass spectrometry (Q24612537) (← links)
- Animals as sentinels of bioterrorism agents (Q24623783) (← links)
- Applications of botulinum toxin in dentistry: A comprehensive review (Q26743715) (← links)
- Pharmacotherapy for the management of achalasia: Current status, challenges and future directions (Q26777632) (← links)
- Plant-produced candidate countermeasures against emerging and reemerging infections and bioterror agents (Q26783107) (← links)
- Endoscopic botox injections in therapy of refractory gastroparesis (Q26801922) (← links)
- Monoclonal Antibody Combinations that Present Synergistic Neutralizing Activity: A Platform for Next-Generation Anti-Toxin Drugs (Q26863621) (← links)
- Therapeutic applications of botulinum neurotoxins in head and neck disorders (Q27024303) (← links)
- Simultaneous Detection of CDC Category "A" DNA and RNA Bioterrorism Agents by Use of Multiplex PCR & RT-PCR Enzyme Hybridization Assays (Q27491037) (← links)
- Botulinum neurotoxin B recognizes its protein receptor with high affinity and specificity (Q27643303) (← links)
- Molecular evolution of antibody cross-reactivity for two subtypes of type A botulinum neurotoxin (Q27643327) (← links)
- Glycosylated SV2 and Gangliosides as Dual Receptors for Botulinum Neurotoxin Serotype F (Q27655649) (← links)
- A Single-Domain Llama Antibody Potently Inhibits the Enzymatic Activity of Botulinum Neurotoxin by Binding to the Non-Catalytic α-Exosite Binding Region (Q27659624) (← links)
- Novel Ganglioside-mediated Entry of Botulinum Neurotoxin Serotype D into Neurons (Q27668123) (← links)
- Structural Framework for Covalent Inhibition of Clostridium botulinum Neurotoxin A by Targeting Cys165 (Q27671266) (← links)
- Unique Ganglioside Recognition Strategies for Clostridial Neurotoxins (Q27671814) (← links)
- Botulinum Neurotoxin Serotype C Associates with Dual Ganglioside Receptors to Facilitate Cell Entry (Q27673821) (← links)
- Structural insights into the functional role of the Hcn sub-domain of the receptor-binding domain of the botulinum neurotoxin mosaic serotype C/D (Q27677003) (← links)
- Botulinum Neurotoxin Is Shielded by NTNHA in an Interlocked Complex (Q27677462) (← links)
- Crystal Structures of Botulinum Neurotoxin DC in Complex with Its Protein Receptors Synaptotagmin I and II (Q27679493) (← links)
- Structure of a Bimodular Botulinum Neurotoxin Complex Provides Insights into Its Oral Toxicity (Q27680382) (← links)
- Structural basis for recognition of synaptic vesicle protein 2C by botulinum neurotoxin A (Q27687569) (← links)
- Botulinum Toxin Treatment for Limb Spasticity in Childhood Cerebral Palsy (Q28074809) (← links)
- Protective antigen and toxin neutralization antibody patterns in anthrax vaccinees undergoing serial plasmapheresis. (Q28384322) (← links)
- Syndromic surveillance and bioterrorism-related epidemics (Q28386064) (← links)
- Production and characterisation of a neutralising chimeric antibody against botulinum neurotoxin A (Q28475753) (← links)
- Mucosal targeting of a BoNT/A subunit vaccine adjuvanted with a mast cell activator enhances induction of BoNT/A neutralizing antibodies in rabbits (Q28476839) (← links)
- Botulinum neurotoxin serotype A specific cell-based potency assay to replace the mouse bioassay (Q28485303) (← links)
- The gene CBO0515 from Clostridium botulinum strain Hall A encodes the rare enzyme N5-(carboxyethyl) ornithine synthase, EC 1.5.1.24 (Q28485608) (← links)
- Phosphatase Inhibitors Function as Novel, Broad Spectrum Botulinum Neurotoxin Antagonists in Mouse and Human Embryonic Stem Cell-Derived Motor Neuron-Based Assays (Q28548051) (← links)
- "Inconvenient truths" in the pursuit of scientific knowledge and public health (Q28660966) (← links)
- Potent new small-molecule inhibitor of botulinum neurotoxin serotype A endopeptidase developed by synthesis-based computer-aided molecular design (Q28750297) (← links)
- Detection of botulinum neurotoxin serotype B at sub mouse LD(50) levels by a sandwich immunoassay and its application to toxin detection in milk (Q28751692) (← links)
- Small molecules showing significant protection of mice against botulinum neurotoxin serotype A (Q28752863) (← links)
- Preparing for biological threats: Addressing the needs of pregnant women (Q28950428) (← links)
- 2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings (Q29619731) (← links)
- Early, Real-Time Medical Diagnosis of Botulism by Endopeptidase-Mass Spectrometry (Q30202543) (← links)
- U.S. Medical Countermeasure Development Since 2001: A Long Way Yet to Go (Q30224689) (← links)
- Treatment of neuroterrorism (Q30224792) (← links)
- Biological warfare agents (Q30226448) (← links)
- Use of sentinel laboratories by clinicians to evaluate potential bioterrorism and emerging infections (Q30230701) (← links)
- A conceptual framework for evaluating information technologies and decision support systems for bioterrorism preparedness and response (Q30233274) (← links)
- Biological weapons preparedness: the role of physicians. (Q30233407) (← links)
- Bioterrorism: pivotal clinical issues. Consensus review of the Society of Infectious Diseases Pharmacists (Q30233435) (← links)
- Bioterrorism - Health emergency preparedness and response (Q30233444) (← links)
- Neurological aspects of chemical and biological terrorism: guidelines for neurologists. (Q30235079) (← links)
- Stability of a trivalent recombinant protein vaccine formulation against botulinum neurotoxin during storage in aqueous solution (Q30371202) (← links)
- Mechanisms of enhanced neutralization of botulinum neurotoxin by monoclonal antibodies conjugated to antibodies specific for the erythrocyte complement receptor (Q30408386) (← links)